Source:http://linkedlifedata.com/resource/pubmed/id/15855365
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2005-4-27
|
pubmed:abstractText |
Autologous chondrocyte implantation (ACI) is used widely as a treatment for symptomatic chondral and osteochondral defects of the knee. Variations of the original periosteum-cover technique include the use of porcine-derived type I/type III collagen as a cover (ACI-C) and matrix-induced autologous chondrocyte implantation (MACI) using a collagen bilayer seeded with chondrocytes. We have performed a prospective, randomised comparison of ACI-C and MACI for the treatment of symptomatic chondral defects of the knee in 91 patients, of whom 44 received ACI-C and 47 MACI grafts. Both treatments resulted in improvement of the clinical score after one year. The mean modified Cincinnati knee score increased by 17.6 in the ACI-C group and 19.6 in the MACI group (p = 0.32). Arthroscopic assessments performed after one year showed a good to excellent International Cartilage Repair Society score in 79.2% of ACI-C and 66.6% of MACI grafts. Hyaline-like cartilage or hyaline-like cartilage with fibrocartilage was found in the biopsies of 43.9% of the ACI-C and 36.4% of the MACI grafts after one year. The rate of hypertrophy of the graft was 9% (4 of 44) in the ACI-C group and 6% (3 of 47) in the MACI group. The frequency of re-operation was 9% in each group. We conclude that the clinical, arthroscopic and histological outcomes are comparable for both ACI-C and MACI. While MACI is technically attractive, further long-term studies are required before the technique is widely adopted.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0301-620X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
87
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
640-5
|
pubmed:dateRevised |
2010-11-10
|
pubmed:meshHeading |
pubmed-meshheading:15855365-Adolescent,
pubmed-meshheading:15855365-Adult,
pubmed-meshheading:15855365-Age Factors,
pubmed-meshheading:15855365-Arthroscopy,
pubmed-meshheading:15855365-Chondrocytes,
pubmed-meshheading:15855365-Female,
pubmed-meshheading:15855365-Humans,
pubmed-meshheading:15855365-Knee Joint,
pubmed-meshheading:15855365-Male,
pubmed-meshheading:15855365-Middle Aged,
pubmed-meshheading:15855365-Orthopedic Procedures,
pubmed-meshheading:15855365-Osteochondritis,
pubmed-meshheading:15855365-Postoperative Complications,
pubmed-meshheading:15855365-Prospective Studies,
pubmed-meshheading:15855365-Reoperation,
pubmed-meshheading:15855365-Time Factors,
pubmed-meshheading:15855365-Treatment Outcome
|
pubmed:year |
2005
|
pubmed:articleTitle |
Autologous chondrocyte implantation versus matrix-induced autologous chondrocyte implantation for osteochondral defects of the knee: a prospective, randomised study.
|
pubmed:affiliation |
Institute of Orthopaedics, Royal National Orthopaedic Hospital, Brockley Hill, Stanmore, Middlesex HA7 4LP, UK. bartlettw@hotmail.com
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|